Effects of supervised aerobic exercise training on serum adiponectin and parameters of lipid and glucose metabolism in subjects with moderate dyslipidemia

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 11, 2010, Pages 1160-1166

  Yoshida, Hiroshi ^a,b,c   Ishikawa, Toshitsugu ^d,e   Suto, Michiko ^d   Kurosawa, Hideo ^a   Hirowatari, Yuji ^f   Ito, Kumie ^c   Yanai, Hidekatsu ^c,g   Tada, Norio ^c   Suzuki, Masato ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JIKEI University Graduate School of Medicine   (Japan)

^d SONY CORPORATION   (Japan)

^e KANAGAWA INSTITUTE OF TECHNOLOGY   (Japan)

^f TOSOH CORPORATION   (Japan)

^g 1 7 1 Kohnodai   (Japan)

Author keywords

Adiponectin; Aerobic exercise training; HOMA R; VLDL cholestero

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AEROBIC EXERCISE; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DYSLIPIDEMIA; FEMALE; GLUCOSE METABOLISM; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 78649869640     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.4358     Document Type: Article

References (33)

1. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vase Biol, 2004; 24: 29-33
2. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest, 2006; 116: 1784-1792
3. Okamoto Y, Kihara S, Funahashi J, Matsuzawa Y, Libby P: Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci, 2006; 110: 267-278
4. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J: The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb, 2005; 12: 295-300
5. Yoshida H, Hirowatari Y, Kurosawa H, Tada N: Implications of decreased serum adiponectin for type lib hyper-lipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients. Clin Sci, 2005; 109: 297-302
6. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J, 2004;68:975-981
7. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vase Biol, 2008; 28: 1039-1049
8. Vu V, Riddell MC, Sweeney G: Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise. Diabetes Metab Res Rev, 2007; 23: 600-611
9. Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, Suzuki E, Shimano H, Yamamoto S, Kondo K, Ohashi Y, Yamada N, Sone H: Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med, 2007; 167: 999-1008
10. Durstine JL, Grandjean PW, Cox CA, Thompson PD: Lipids, lipoproteins, and exercise. J Cardiopulm Rehabil, 2002; 22: 385-398
11. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M: Treatment-Therapeutic lifestyle modification. J Atheroscler Thromb, 2008; 15: 109-115
12. Hirowatari Y, Yoshida H, Kurosawa H, Doumitsu K, Tada N: Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J Lipid Res, 2003; 44: 1404-1412
13. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takay-anagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T, Nakano Y: Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes, 2006; 55: 1954-1960
14. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC: Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia, 1985;28:401-411
15. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Pories WJ, MacDonald KG, Dohm GL: Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab, 2002; 283: E861-E865
16. Kobayashi J, Murase Y, Asano A, Nohara A, Kawashiri MA, Inazu A, Yamagishi M, Mabuchi H: Effect of walking with a pedometer on serum lipid and adiponectin levels in Japanese middle-aged men. J Atheroscler Thromb, 2006; 13: 197-201
17. Bobbert T, Wegewitz U, Brechtel L, Freudenberg M, Mai K, Möhlig M, Diederich S, Ristow M, Rochlitz H, Pfei-ffer AF Spranger J: Adiponectin oligomers in human serum during acute and chronic exercise: relation to lipid metabolism and insulin sensitivity. Int J Sports Med, 2007; 28: 1-8
18. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD: Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care, 2006; 29: 1433-1438
19. Henriksen EJ: Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. J Appl Physiol, 2002; 93: 788-796
20. Simpson KA, Singh MA: Effects of exercise on adiponectin: a systematic review. Obesity, 2008; 16: 241-256
21. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab, 2001;86:3815-3819
22. Blüher M, Bullen JW Jr, Lee JH, Kralisch S, Fasshauer M, Kloting N, Niebauer J, Schon MR, Williams CJ, Mantzo-ros CS: Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab, 2006;91:2310-2316
23. Ando D, Hosaka Y, Suzuki K, Yamagata Z: Effects of exercise training on circulating high molecular weight adiponectin and adiponectin oligomer composition: a randomized controlled trial. J Atheroscler Thromb, 2009; 16: 733-739
24. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S: Hypoadiponec-tinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism, 2003; 52: 1274-1278
25. Mori I, Ishizuka T, Morita H, Matsumoto M, Uno Y, Kajita K, Ikeda T, Fujioka K, Matsubara K: Comparison of biochemical data, blood pressure and physical activity between longevity and non-longevity districts in Japan. Circ J, 2008; 72: 1680-1684
26. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem, 2003; 278: 40352-40363
27. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 2006; 29: 1357-1362
28. Bliüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer N, Kralisch S, Williams CJ, Mantzoros CS: Total and High-Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program. Diabetes Care, 2007; 30: 280-285
29. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, Okada T, Nakagawa Y, Tamba S, Kuroda Y, Hayashi N, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Funahashi T, Matsuzawa Y: Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J, 2008; 72: 23-28
30. Couillard C, Després JP, Lamarche B, Bergeron J, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arte-rioscler Thromb Vase Biol, 2001; 21: 1226-1232
31. Tsekouras YE, Magkos F, Kellas Y, Basioukas KN, Kavou-ras SA, Sidossis LS: High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-triglycer-ide secretion rate in men. Am J Physiol Endocrinol Metab, 2008; 295: E851-E858
32. Alam S, Stolinski M, Pentecost C, Boroujerdi MA, Jones RH, Sonksen PH, Umpleby AM: The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab, 2004; 89: 688-694
33. Qiao L, Zou C, van der Westhuyzen DR, Shao J: Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes, 2008; 57: 1824-1833